A trial to study the efficacy of quadrivalent HPV vaccine in anogenital wart
Not Applicable
- Conditions
- Health Condition 1: B078- Other viral warts
- Registration Number
- CTRI/2023/06/053364
- Lead Sponsor
- Dr s.n medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient of all genders >8 years
Signed informed consent form
Confirmed clinical diagnosis of genital condylomata
Exclusion Criteria
Individuals who are pregnant or are planning to become pregnant
Participant allergic to yeast and vaccine components
Patient who have received prior human papilloma virus vaccine
Subjects who are immunocompromised or are on immunosuppressive medications or on immunomodulatory agents will be excluded
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in wart number between week 0 and week 12 <br/ ><br>Change in mean size of genital condyloma between week 0 and week 12Timepoint: Changes in wart number between week 0 and week 12
- Secondary Outcome Measures
Name Time Method Change in score of specific questionnaire for condyloma accuminata (CECA) <br/ ><br>Change in score of dermatology quality of life index (DLQI)Timepoint: Week 0 and Week 12